0001213900-19-009185.txt : 20190520 0001213900-19-009185.hdr.sgml : 20190520 20190520143858 ACCESSION NUMBER: 0001213900-19-009185 CONFORMED SUBMISSION TYPE: 1-A-W PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190520 DATE AS OF CHANGE: 20190520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emerald Health Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001700800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820669961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 1-A-W SEC ACT: 1933 Act SEC FILE NUMBER: 024-10810 FILM NUMBER: 19838373 BUSINESS ADDRESS: STREET 1: 5910 PACIFIC CENTER BLVD STREET 2: SUITE 300, CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 352-0622 MAIL ADDRESS: STREET 1: 5910 PACIFIC CENTER BLVD STREET 2: SUITE 300, CITY: SAN DIEGO STATE: CA ZIP: 92121 1-A-W 1 f1aw052019_emeraldhealth.htm WITHDRAWAL OF OFFERING STATEMENT UNDER REGULATION A

EMERALD HEALTH PHARMACEUTICALS INC.

5910 Pacific Center Blvd, Ste 300

San Diego, California 92121

(800) 268-0719

May 20, 2019

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

RE:

Emerald Health Pharmaceuticals Inc.

Withdrawal of Post-Qualification Amendment No. 2 to Offering Statement.

Filed May 15, 2019

File Number 024-10810

Dear Madam/Sir,

Emerald Health Pharmaceuticals Inc., hereby requests that the Securities and Exchange Commission consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Company’s Amended Regulation A Offering Statement filed on May 15, 2019 under an incorrect Form type 1-A/A (File No. 024-10810).

The filing has been resubmitted under the correct Form type 1-A POS.

If you have any questions, please do not hesitate to contact us.

Sincerely,

/s/ Lisa Sanford
CFO

cc:	Dr. James DeMesa
	CEO